KR20110020797A - 이속사졸 유도체 및 대사성 글루타메이트 수용체 강화제로서의 그의 용도 - Google Patents

이속사졸 유도체 및 대사성 글루타메이트 수용체 강화제로서의 그의 용도 Download PDF

Info

Publication number: KR20110020797A
Authority: KR; South Korea
Prior art keywords: methyl; dihydro; ethyl; chloro; isoindol
Prior art date: 2008-06-06

Application number

KR1020107027224A

Other languages

English (en)

Korean (ko)

Inventor

조셉 카시올라

제임스 엠필드

제임스 폴머

안젤라 엠 헌터

스콧 트로너

Original Assignee

아스트라제네카 아베

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-06-06

Filing date

2009-06-08

Publication date

2011-03-03

2009-06-08 Application filed by 아스트라제네카 아베 filed Critical 아스트라제네카 아베

2011-03-03 Publication of KR20110020797A publication Critical patent/KR20110020797A/ko

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/08—Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound
- A61B17/083—Clips, e.g. resilient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/08—Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound
- A61B17/085—Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound with adhesive layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/10—Surgical instruments, devices or methods, e.g. tourniquets for applying or removing wound clamps, e.g. containing only one clamp or staple; Wound clamp magazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/10—Surgical instruments, devices or methods, e.g. tourniquets for applying or removing wound clamps, e.g. containing only one clamp or staple; Wound clamp magazines
- A61B17/105—Wound clamp magazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

KR1020107027224A 2008-06-06 2009-06-08 이속사졸 유도체 및 대사성 글루타메이트 수용체 강화제로서의 그의 용도 KR20110020797A (ko)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5948508P	2008-06-06	2008-06-06
US61/059,485		2008-06-06

Publications (1)

Publication Number	Publication Date
KR20110020797A true KR20110020797A (ko)	2011-03-03

Family

ID=41398335

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
KR1020107027224A KR20110020797A (ko)	2008-06-06	2009-06-08	이속사졸 유도체 및 대사성 글루타메이트 수용체 강화제로서의 그의 용도

Country Status (40)

Country	Link
US (4)	US7790760B2 (ar)
EP (2)	EP2772492B1 (ar)
JP (2)	JP5476371B2 (ar)
KR (1)	KR20110020797A (ar)
CN (1)	CN102105466B (ar)
AR (1)	AR072016A1 (ar)
AU (1)	AU2009255784B2 (ar)
BR (1)	BRPI0913585A2 (ar)
CA (1)	CA2726925A1 (ar)
CL (1)	CL2010001348A1 (ar)
CO (1)	CO6321239A2 (ar)
CR (1)	CR11826A (ar)
CU (1)	CU23883B1 (ar)
CY (1)	CY1115301T1 (ar)
DK (1)	DK2303872T3 (ar)
DO (1)	DOP2010000375A (ar)
EA (2)	EA018412B1 (ar)
EC (1)	ECSP10010662A (ar)
ES (1)	ES2469837T3 (ar)
GT (1)	GT201000342A (ar)
HK (2)	HK1155744A1 (ar)
HN (1)	HN2010002582A (ar)
HR (1)	HRP20140451T1 (ar)
IL (1)	IL209622A0 (ar)
MX (1)	MX2010012949A (ar)
MY (1)	MY156552A (ar)
NI (3)	NI201000209A (ar)
NZ (1)	NZ590344A (ar)
PE (1)	PE20110028A1 (ar)
PL (1)	PL2303872T3 (ar)
PT (1)	PT2303872E (ar)
RS (1)	RS53392B (ar)
SA (1)	SA109300358B1 (ar)
SI (1)	SI2303872T1 (ar)
SV (1)	SV2010003751A (ar)
TW (3)	TWI382027B (ar)
UA (1)	UA107649C2 (ar)
UY (1)	UY31870A (ar)
WO (1)	WO2009148403A1 (ar)
ZA (1)	ZA201008611B (ar)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI417095B (zh)	2006-03-15	2013-12-01	Janssen Pharmaceuticals Inc	１，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途
TW200845978A (en)	2007-03-07	2008-12-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en)	2007-03-07	2009-01-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
SI2203439T1 (sl)	2007-09-14	2011-05-31	Ortho Mcneil Janssen Pharm	1',3'-disubstituirani 4-fenil-3,4,5,6-tetrahidro-2H-1'H-(1,4')bipiridinil-2'-oni
ES2409215T3 (es)	2007-09-14	2013-06-25	Janssen Pharmaceuticals, Inc.	4-fenil-1H-piridin-2-onas 1-3-disustituidas
SA109300358B1 (ar) *	2008-06-06	2012-11-03	استرازينيكا ايه بي	مقويات مستقبل جلوتامات ذي انتحاء أيضي من أيزو إندولون
BRPI0918055A2 (pt)	2008-09-02	2015-12-01	Addex Pharmaceuticals Sa	derivados de 3-azabiciclo[3,1,0]hexila como moduladores de receptores metabotrópicos de glutamato.
WO2010043396A1 (en)	2008-10-16	2010-04-22	Ortho-Mcneil-Janssen Pharmaceuticals, Inc.	Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
ME01573B (me)	2009-05-12	2014-09-20	Addex Pharma Sa	DERIVATI 1,2,4-TRIAZOLO[4,3-a]PIRIDINA I NJIHOVA UPOTREBA U TRETMANU ILI PREVENCIJI NEUROLOŠKIH I PSIHIJATRIJSKIH POREMEĆAJA
BRPI1010831A2 (pt)	2009-05-12	2016-04-05	Addex Pharmaceuticals Sa	derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2
MY153913A (en)	2009-05-12	2015-04-15	Janssen Pharmaceuticals Inc	7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
JP5852664B2 (ja)	2010-11-08	2016-02-03	ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド	１，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
US8993591B2 (en)	2010-11-08	2015-03-31	Janssen Pharmaceuticals, Inc.	1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
WO2012062751A1 (en)	2010-11-08	2012-05-18	Janssen Pharmaceuticals, Inc.	1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
JO3368B1 (ar)	2013-06-04	2019-03-13	Janssen Pharmaceutica Nv	مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar)	2013-09-06	2019-03-13	Janssen Pharmaceutica Nv	مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
SI3431106T1 (sl)	2014-01-21	2021-03-31	Janssen Pharmaceutica Nv	Kombinacije, ki vsebujejo pozitivne alosterične modulatorje metabotropnega glutamatergičnega receptorja podtipa 2 in njihova uporaba
LT3096790T (lt)	2014-01-21	2019-10-10	Janssen Pharmaceutica, N.V.	Deriniai, apimantys 2 potipio metabotropinio glutamaterginio receptoriaus teigiamus alosterinius moduliatorius arba ortosterinius agonistus, ir jų panaudojimas
WO2015157187A1 (en)	2014-04-06	2015-10-15	Sanford-Burnham Medical Research Institute	Metabotropic glutamate receptor positive allosteric modulators (pams) and uses thereof
KR101663662B1 (ko) *	2015-06-17	2016-10-14	한국과학기술연구원	대사성 글루타메이트 수용체 1에 활성을 지닌 신규 아릴 아이소옥사졸 유도체
WO2017089892A1 (en) *	2015-11-25	2017-06-01	Astrazeneca Ab	Deuterated isoxazole derivatives and their use as metabotropic glutamate receptor potentiators
US10807680B2 (en)	2016-10-21	2020-10-20	National Tsing Hua University	Mooring system and method for power generation systems and other payloads in water flows
WO2020102216A1 (en)	2018-11-13	2020-05-22	Incyte Corporation	Substituted heterocyclic derivatives as pi3k inhibitors
US11078204B2 (en)	2018-11-13	2021-08-03	Incyte Corporation	Heterocyclic derivatives as PI3K inhibitors
WO2020102150A1 (en)	2018-11-13	2020-05-22	Incyte Corporation	Heterocyclic derivatives as pi3k inhibitors

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE620654C (de)	1933-04-29	1935-10-24	Smith & Sons Ltd S	Geschwindigkeitsanzeiger
US3993617A (en)	1975-10-30	1976-11-23	Morton-Norwich Products, Inc.	Antifungal 2-substituted phthalimidines
US5175157A (en)	1985-11-27	1992-12-29	Boehringer Ingelheim Gmbh	Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them
WO1992017448A1 (en)	1991-04-01	1992-10-15	Kyowa Hakko Kogyo Co., Ltd.	3-methyleneisoindolin-1-one derivative
TW219935B (ar)	1991-12-25	1994-02-01	Mitsubishi Chemicals Co Ltd
EP0602814A1 (en)	1992-12-18	1994-06-22	Takeda Chemical Industries, Ltd.	Crystal forms of optically active isoindolines and their use
US5681954A (en)	1993-05-14	1997-10-28	Daiichi Pharmaceutical Co., Ltd.	Piperazine derivatives
CA2245586A1 (en)	1996-02-06	1997-08-14	Japan Tobacco Inc.	Novel compounds and pharmaceutical use thereof
EP0999208A4 (en)	1997-05-30	2001-08-08	Meiji Seika Kaisha	NITROGEN-BASED HETEROCYCLIC COMPOUNDS AND MEDICINES FOR TREATING HYPERLIPEMIA THAT CONTAIN THEM
JP2001524468A (ja)	1997-11-21	2001-12-04	エヌピーエスファーマシューティカルズインコーポレーテッド	中枢神経系疾患を治療するための代謝調節型グルタミン酸受容体アンタゴニスト
IL151533A0 (en)	2000-02-29	2003-04-10	Mitsubishi Pharma Corp	Novel cyclic amide derivatives
AP2003002720A0 (en)	2000-07-31	2003-06-30	Smithkline Beecham Plc	Carboxamide compounds and their use as antagonists of a human 11 CBY receptor.
US7491748B2 (en)	2001-08-09	2009-02-17	Ono Pharmaceutical Co., Ltd.	Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
WO2003087044A2 (en)	2002-04-09	2003-10-23	7Tm Pharma A/S	Novel carboxamide compounds for use in mch receptor related disorders
FR2840302B1 (fr)	2002-06-03	2004-07-16	Aventis Pharma Sa	Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
DE10238865A1 (de)	2002-08-24	2004-03-11	Boehringer Ingelheim International Gmbh	Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
GB0223232D0 (en)	2002-10-07	2002-11-13	Pfizer Ltd	Chemical compounds
US7507836B2 (en)	2003-03-26	2009-03-24	Merck & Co. Inc.	Benzamide modulators of metabotropic glutamate receptors
GB0308025D0 (en)	2003-04-07	2003-05-14	Glaxo Group Ltd	Compounds
US7129260B2 (en)	2003-06-02	2006-10-31	Abbott Laboratories	Isoindolinone kinase inhibitors
US20070135485A1 (en)	2003-10-22	2007-06-14	Gillig James R	Novel mch receptor antagonists
EP1713775A4 (en)	2004-01-30	2009-08-12	Smithkline Beecham Corp	CHEMICAL COMPOUNDS
PL1716152T3 (pl)	2004-02-18	2009-01-30	Astrazeneca Ab	Skondensowane związki heterocykliczne i ich zastosowanie jako antagonistów receptora metabotropowego do leczenia zaburzeń żołądkowo-jelitowych
CA2558278A1 (en)	2004-03-05	2005-09-15	Banyu Pharmaceutical Co., Ltd.	Diaryl-substituted five-membered heterocycle derivative
JP4883296B2 (ja)	2004-03-05	2012-02-22	日産化学工業株式会社	イソキサゾリン置換ベンズアミド化合物及び有害生物防除剤
SE0400970D0 (sv)	2004-04-14	2004-04-14	Astrazeneca Ab	Nicotinic acetylcholine receptor ligands
TW200613272A (en)	2004-08-13	2006-05-01	Astrazeneca Ab	Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
AU2005299797A1 (en)	2004-10-25	2006-05-04	Merck & Co., Inc.	Heterocyclic indanone potentiators of metabotropic glutamate receptors
AU2006216917A1 (en)	2005-02-24	2006-08-31	Merck Sharp & Dohme Corp.	Benzazole potentiators of metabotropic glutamate receptors
EA015813B1 (ru)	2005-05-18	2011-12-30	Аддекс Фарма Са	Замещенные производные оксадиазола в качестве положительных аллостерических модуляторов метаботропных глутаматных рецепторов
GB0510142D0 (en)	2005-05-18	2005-06-22	Addex Pharmaceuticals Sa	Novel compounds A1
TW200728277A (en)	2005-06-29	2007-08-01	Palau Pharma Sa	Bicyclic derivatives as P38 inhibitors
CN101277934A (zh)	2005-08-12	2008-10-01	阿斯利康(瑞典)有限公司	使代谢型谷氨酸-受体-增效的异吲哚酮
US7868008B2 (en) *	2005-08-12	2011-01-11	Astrazeneca Ab	Substituted isoindolones and their use as metabotropic glutamate receptor potentiators
US7807706B2 (en)	2005-08-12	2010-10-05	Astrazeneca Ab	Metabotropic glutamate-receptor-potentiating isoindolones
EP1934214B1 (en)	2005-09-27	2010-04-07	F.Hoffmann-La Roche Ag	Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists
TW200804281A (en) *	2006-02-16	2008-01-16	Astrazeneca Ab	New metabotropic glutamate receptor-potentiating isoindolones
TW200911255A (en)	2007-06-07	2009-03-16	Astrazeneca Ab	Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators-841
TWI417100B (zh)	2007-06-07	2013-12-01	Astrazeneca Ab	二唑衍生物及其作為代謝型麩胺酸受體增效劑-８４２之用途
SA109300358B1 (ar) *	2008-06-06	2012-11-03	استرازينيكا ايه بي	مقويات مستقبل جلوتامات ذي انتحاء أيضي من أيزو إندولون

2009
- 2009-06-03 SA SA109300358A patent/SA109300358B1/ar unknown
- 2009-06-03 US US12/477,347 patent/US7790760B2/en not_active Expired - Fee Related
- 2009-06-04 TW TW098118593A patent/TWI382027B/zh not_active IP Right Cessation
- 2009-06-04 TW TW103145569A patent/TW201514173A/zh unknown
- 2009-06-04 TW TW101129417A patent/TWI477499B/zh not_active IP Right Cessation
- 2009-06-05 AR ARP090102031A patent/AR072016A1/es unknown
- 2009-06-05 UY UY0001031870A patent/UY31870A/es not_active Application Discontinuation
- 2009-06-08 AU AU2009255784A patent/AU2009255784B2/en not_active Ceased
- 2009-06-08 DK DK09758630.9T patent/DK2303872T3/da active
- 2009-06-08 EA EA201001724A patent/EA018412B1/ru not_active IP Right Cessation
- 2009-06-08 MY MYPI2010005780A patent/MY156552A/en unknown
- 2009-06-08 MX MX2010012949A patent/MX2010012949A/es active IP Right Grant
- 2009-06-08 PT PT97586309T patent/PT2303872E/pt unknown
- 2009-06-08 ES ES09758630.9T patent/ES2469837T3/es active Active
- 2009-06-08 KR KR1020107027224A patent/KR20110020797A/ko active IP Right Grant
- 2009-06-08 BR BRPI0913585A patent/BRPI0913585A2/pt not_active IP Right Cessation
- 2009-06-08 UA UAA201014034A patent/UA107649C2/uk unknown
- 2009-06-08 RS RS20140295A patent/RS53392B/en unknown
- 2009-06-08 CN CN200980129149.7A patent/CN102105466B/zh not_active Expired - Fee Related
- 2009-06-08 WO PCT/SE2009/050682 patent/WO2009148403A1/en active Application Filing
- 2009-06-08 PL PL09758630T patent/PL2303872T3/pl unknown
- 2009-06-08 EP EP14164664.6A patent/EP2772492B1/en active Active
- 2009-06-08 CA CA2726925A patent/CA2726925A1/en not_active Abandoned
- 2009-06-08 JP JP2011512416A patent/JP5476371B2/ja not_active Expired - Fee Related
- 2009-06-08 SI SI200930928T patent/SI2303872T1/sl unknown
- 2009-06-08 PE PE2010001111A patent/PE20110028A1/es not_active Application Discontinuation
- 2009-06-08 NZ NZ590344A patent/NZ590344A/en not_active IP Right Cessation
- 2009-06-08 EP EP09758630.9A patent/EP2303872B1/en active Active
- 2009-06-08 EA EA201300342A patent/EA201300342A1/ru unknown
- 2009-10-08 US US12/575,891 patent/US7781434B2/en not_active Expired - Fee Related
2010
- 2010-08-13 NI NI201000209A patent/NI201000209A/es unknown
- 2010-08-20 US US12/860,330 patent/US8148372B2/en not_active Expired - Fee Related
- 2010-08-26 US US12/869,263 patent/US7888353B2/en not_active Expired - Fee Related
- 2010-11-26 CO CO10149429A patent/CO6321239A2/es active IP Right Grant
- 2010-11-29 IL IL209622A patent/IL209622A0/en unknown
- 2010-11-30 ZA ZA2010/08611A patent/ZA201008611B/en unknown
- 2010-12-03 CL CL2010001348A patent/CL2010001348A1/es unknown
- 2010-12-06 NI NI2010002092A patent/NI201002092A/es unknown
- 2010-12-06 CU CU20100238A patent/CU23883B1/es not_active IP Right Cessation
- 2010-12-06 DO DO2010000375A patent/DOP2010000375A/es unknown
- 2010-12-06 NI NI2010002091A patent/NI201002091A/es unknown
- 2010-12-06 GT GT201000342A patent/GT201000342A/es unknown
- 2010-12-06 HN HN2010002582A patent/HN2010002582A/es unknown
- 2010-12-06 SV SV2010003751A patent/SV2010003751A/es not_active Application Discontinuation
- 2010-12-06 CR CR11826A patent/CR11826A/es unknown
- 2010-12-07 EC EC2010010662A patent/ECSP10010662A/es unknown
2011
- 2011-09-23 HK HK11110043.3A patent/HK1155744A1/xx not_active IP Right Cessation
2014
- 2014-02-06 JP JP2014020956A patent/JP5815765B2/ja not_active Expired - Fee Related
- 2014-05-21 HR HRP20140451AT patent/HRP20140451T1/hr unknown
- 2014-06-11 CY CY20141100416T patent/CY1115301T1/el unknown
2015
- 2015-02-13 HK HK15101607.6A patent/HK1201255A1/xx unknown

Also Published As

Publication number	Publication date
AU2009255784A1 (en)	2009-12-10
HK1201255A1 (en)	2015-08-28
NI201000209A (es)	2012-11-07
US20100317662A1 (en)	2010-12-16
AR072016A1 (es)	2010-07-28
HK1155744A1 (en)	2012-05-25
CA2726925A1 (en)	2009-12-10
EP2303872A1 (en)	2011-04-06
ES2469837T3 (es)	2014-06-20
CU20100238A7 (es)	2011-11-15
UA107649C2 (uk)	2015-02-10
US7888353B2 (en)	2011-02-15
SI2303872T1 (sl)	2014-06-30
CY1115301T1 (el)	2017-01-04
US20100324044A1 (en)	2010-12-23
NZ590344A (en)	2012-07-27
GT201000342A (es)	2015-02-16
CU23883B1 (es)	2013-04-19
CL2010001348A1 (es)	2011-03-25
EA018412B1 (ru)	2013-07-30
US20090306158A1 (en)	2009-12-10
PT2303872E (pt)	2014-06-23
SA109300358B1 (ar)	2012-11-03
CO6321239A2 (es)	2011-09-20
JP2011522816A (ja)	2011-08-04
HN2010002582A (es)	2012-08-27
NI201002092A (es)	2012-11-07
DOP2010000375A (es)	2010-12-31
CR11826A (es)	2011-02-04
WO2009148403A1 (en)	2009-12-10
EP2303872B1 (en)	2014-04-16
IL209622A0 (en)	2011-02-28
TWI477499B (zh)	2015-03-21
US8148372B2 (en)	2012-04-03
BRPI0913585A2 (pt)	2015-10-27
JP5476371B2 (ja)	2014-04-23
PE20110028A1 (es)	2011-02-11
US20100022545A1 (en)	2010-01-28
CN102105466A (zh)	2011-06-22
MX2010012949A (es)	2010-12-15
ZA201008611B (en)	2012-05-30
JP5815765B2 (ja)	2015-11-17
EA201001724A1 (ru)	2011-08-30
EA201300342A1 (ru)	2014-02-28
SV2010003751A (es)	2011-04-14
TWI382027B (zh)	2013-01-11
NI201002091A (es)	2012-11-07
TW201247658A (en)	2012-12-01
JP2014114312A (ja)	2014-06-26
UY31870A (es)	2010-01-29
TW201002699A (en)	2010-01-16
RS53392B (en)	2014-10-31
PL2303872T3 (pl)	2014-08-29
HRP20140451T1 (hr)	2014-08-01
DK2303872T3 (da)	2014-06-16
EP2303872A4 (en)	2012-03-21
EP2772492B1 (en)	2016-08-17
CN102105466B (zh)	2014-10-15
AU2009255784B2 (en)	2012-08-16
US7790760B2 (en)	2010-09-07
ECSP10010662A (es)	2011-01-31
EP2772492A1 (en)	2014-09-03
US7781434B2 (en)	2010-08-24
MY156552A (en)	2016-02-26
TW201514173A (zh)	2015-04-16

Legal Events

Date	Code	Title
2014-06-05	A201	Request for examination
2015-10-08	E902	Notification of reason for refusal
2016-04-22	E701	Decision to grant or registration of patent right

Publication	Publication Date	Title
KR20110020797A (ko)	2011-03-03	이속사졸 유도체 및 대사성 글루타메이트 수용체 강화제로서의 그의 용도
JP5416696B2 (ja)	2014-02-12	オキサジアゾール誘導体およびそれらの代謝型グルタミン酸受容体増強剤としての使用
JP2010529117A (ja)	2010-08-26	代謝型グルタミン酸受容体オキサジアゾールリガンドおよびそれらの増強剤としての使用
US20090149505A1 (en)	2009-06-11	Metabotropic Glutamate Receptor-Potentiating Isoindolones
JP2008534543A (ja)	2008-08-28	オキサゾール部分又はチアゾリン部分を含む化合物、それらの製造方法及びそれらの使用
AU2012251943B2 (en)	2014-09-25	Isoxazole derivatives and their use as metabotropic glutamate receptor potentiators